ROSEMARIE SCHMANDT to Everolimus
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Everolimus.
Connection Strength
0.197
-
Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications. J Control Release. 2021 11 10; 339:521-530.
Score: 0.172
-
The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. Int J Gynecol Cancer. 2014 May; 24(4):713-7.
Score: 0.026